C-Terminal PEGylation Improves SAAP-148 Peptide’s Immunomodulatory Activities
Journal of Innate Immunity · 2023 · 15 (1) · 724-738
DOI: 10.1159/000534068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, online erschienen am 19.09.2023. Verfasst von Miriam E van Gent und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Monocytes, Anti-Bacterial Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Synthetic antibacterial and anti-biofilm peptide (SAAP)-148 was developed to combat bacterial infections not effectively treatable with current antibiotics. SAAP-148 is highly effective against antimicrobial-resistant bacteria without inducing resistance; however, challenges for further development of SAAP-148 include its cytotoxicity and short circulation half-life. To circumvent these drawbacks, a library of SAAP-148 linked to polyethylene glycol (PEG) groups of various lengths was synthesized and screened for in vitro antibacterial activity and hemolytic activity. Results indicated that PEGylated SAAP-148 variants combine antibacterial activities with reduced hemolysis compared to SAAP-148. Interestingly, proinflammatory immunomodulatory activities of SAAP-148 were enhanced upon C-terminal PEGylation, with SAAP-148-PEG27 showing the most effect. SAAP-148-PEG27 enhanced SAAP-148’s capacity to chemoattract human neutrophils and was able to more efficiently (re)direct M-CSF-induced monocyte-macrophage differentiation toward type 1 macrophages as opposed to SAAP-148. Furthermore, dendritic cells with a stronger mature expression profile were produced if monocytes were exposed to SAAP-148-PEG27 during monocyte-immature dendritic cell differentiation in comparison to SAAP-148. Parameters that influenced the immunomodulatory activities of the peptide-PEG conjugate include (i) the length of the PEG group, (ii) the position of PEG conjugation, and (iii) the peptide sequence. Together, these results indicate that SAAP-148-PEG27 is highly effective in redirecting monocyte-macrophage differentiation toward a proinflammatory phenotype and promoting monocyte-mature dendritic cell development. Therefore, SAAP-148-PEG27 may be a promising agent to modulate inadequate immune responses in case of tumors and chronically infected wounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Zitieren
APA
van Gent, M. E., Schonkeren-Ravensbergen, B., Achkif, A., Beentjes, D., Dolezal, N., van Meijgaarden, K. E., Drijfhout, J. W., & Nibbering, P. H. (2023). C-Terminal PEGylation Improves SAAP-148 Peptide’s Immunomodulatory Activities. Journal of Innate Immunity, 15(1), 724-738. https://doi.org/10.1159/000534068
Vancouver
van Gent ME, Schonkeren-Ravensbergen B, Achkif A, Beentjes D, Dolezal N, van Meijgaarden KE, et al. C-Terminal PEGylation Improves SAAP-148 Peptide’s Immunomodulatory Activities. Journal of Innate Immunity. 2023;15(1):724-738. doi:10.1159/000534068
BibTeX
@article{vanGent2023,
author = {van Gent, Miriam E and Schonkeren-Ravensbergen, Bep and Achkif, Asma and Beentjes, Daan and Dolezal, Natasja and van Meijgaarden, Krista E and Drijfhout, Jan Wouter and Nibbering, Peter H},
title = {C-Terminal PEGylation Improves SAAP-148 Peptide’s Immunomodulatory Activities},
journal = {Journal of Innate Immunity},
year = {2023},
volume = {15},
number = {1},
pages = {724--738},
doi = {10.1159/000534068}
}
EUVIMED